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V(D)J gene segment recombination is linked to the
cell cycle by the periodic phosphorylation and
destruction of the RAG-2 protein at the G1-to-S cell
cycle transition. To examine the function of this
coupling, we constructed mice in which the phos-
phorylation site at threonine 490 of RAG-2 was
mutated to alanine. The RAG-2(T490A) mutation
uncoupled DNA cleavage from cell cycle and
promoted aberrant recombination. Similar aberrant
recombination products were observed in mice defi-
cient in the Skp2 ubiquitin ligase subunit, which is
required for periodic destruction of RAG-2. On
a p53-deficient background, the RAG-2(T490A)
mutation induced lymphoid malignancies character-
ized by clonal chromosomal translocations involving
antigen receptor genes. Taken together, these obser-
vations provide a direct link between the periodic
destruction of RAG-2 and lymphoid tumorigenesis.
We infer that cell cycle control of the V(D)J recombi-
nase limits the potential genomic damage that could
otherwise result from RAG-mediated DNA cleavage.
INTRODUCTION
The genes that encode antigen receptors are assembled from
discrete DNA segments that are brought together during
lymphocyte development by variable-diversity-joining (V(D)J)
recombination (Gellert, 2002). The recombination activating
gene (RAG) proteins RAG-1 and RAG-2 initiate rearrangement
by cleaving participating gene segments at recombination signal
sequences (RSSs). DNA cleavage produces signal ends, which
terminate in flush, double-stranded breaks, and coding ends,
which terminate in hairpin structures (Gellert, 2002). Recombina-
tion is completed by the RAG proteins and components of the
machinery for DNA double-strand break repair (DSBR) (Fug-
mann et al., 2000; Gellert, 2002).
There are two general mechanisms for DSBR in eukaryotic
cells: nonhomologous end joining (NHEJ) and homologousrecombination (HR). NHEJ, which is essential for V(D)J recombi-
nation, is carried out by a suite of proteins that includes Ku70,
Ku80, artemis, DNA-PKcs, XRCC4, DNA ligase IV, and XLF,
also known as Cernunnos (Ahnesorg et al., 2006; Buck et al.,
2006; Lieber et al., 2003). The importance of NHEJ inmaintaining
genomic stability is demonstrated by the frequent lymphoid
tumors and associated chromosomal translocations observed
in mice doubly deficient in NHEJ and DNA damage-induced
apoptosis. Mice lacking XRCC4 and the proapoptotic protein
p53 (Gao et al., 2000) or Ku80 (Difilippantonio et al., 2000)
succumb to pro-B lymphomas carrying translocations involving
Igh andMyc, consistent with a role for NHEJ in protection against
oncogenic consequences of RAG-mediated DNA cleavage
(Difilippantonio et al., 2000; Gao et al., 2000; Zhu et al., 2002).
In mammalian cells, NHEJ predominates during the G1 and
early S cell cycle phases, whereas HR and NHEJ are both em-
ployed in late S and G2 (Fukushima et al., 2001; Takata et al.,
1998). The RAG proteins preferentially direct DNA ends into
the NHEJ pathway and some RAG mutations that impair joining
favor repair by HR or an alternative form of NHEJ (Corneo et al.,
2007; Lee et al., 2004). Initiation of V(D)J recombination is also
sequestered temporally from HR by the periodic destruction of
RAG-2. RAG-2 accumulates in the G0 and G1 cell cycle phases
and is rapidly degraded at the G1-to-S transition (Li et al., 1996;
Lin and Desiderio, 1993, 1994). Consequently, accumulation of
recombination intermediates (Desiderio et al., 1996; Schlissel
et al., 1993) and RAG-signal end complexes (Jiang et al., 2004)
is restricted to G0 and G1. Destruction of RAG-2 is triggered
upon phosphorylation of threonine 490 by cyclin A-Cdk2 (Jiang
et al., 2005; Lee and Desiderio, 1999; Li et al., 1996), which
creates a binding site for the Skp2-SCF ubiquitin ligase, a regu-
lator of cell cycle progression (Jiang et al., 2005). Upon its
polyubiquitination by Skp2-SCF, RAG-2 is degraded by the
proteasome (Jiang et al., 2005).
The restriction of RAG activity to G0 and G1 limits RSS
cleavage to times at which double-strand DNA repair proceeds
predominantly by NHEJ. To understand the physiologic
relevance of this restriction, we generated mice in which the
Cdk2 phosphorylation site at threonine 490 of RAG-2 was
mutated to alanine. Our observations indicate that restriction of
RAG activity to the G0-G1 cell cycle phases protects against
potential genomic instability arising from V(D)J recombination.
Just as the RAG complex physically sequesters DNA endsImmunity 34, 163–174, February 25, 2011 ª2011 Elsevier Inc. 163
Figure 1. Uncoupling of V(D)J Recombina-
tion fromCell Cycle inRag2(T490A) Knockin
Mice
(A) Generation of Rag2(T490A) knockin mice. Top,
wild-type Rag2 allele (WT); middle, neo-excised
Rag2(T490A) allele (T490A); bottom, neo-excised,
wild-type Rag2 allele (WT*). Open box, Rag2
coding exon. Direction of transcription is right to
left. Filled triangle, loxP site; P, PstI; B, BamHI;
asterisk, location of nucleotide substitutions spec-
ifying the T490A mutation and a novel PstI restric-
tion site. Bar, probe used to assay recombinants
by Southern hybridization. Dots below indicate
positions of forward (black) and reverse (gray)
PCR primers used for genotyping. Sizes of restric-
tion fragments, in kb, are indicated below.
(B) Assay for wild-type (WT), neo-excised wild-
type (WT*), and neo-excised mutant (T490A)
alleles. Genomic DNA was screened by PCR
(left) with primers indicated in (A). Sizes of ampli-
cons are indicated in bp. Genotypes were
confirmed by Southern hybridization (right).
Genomic DNA was digested with PstI and hybrid-
ized to the probe indicated in (A). Sizes of products
are indicated in kb.
(C) Cell cycle independence of RAG-2 accumula-
tion in RAG-2 T490A mice. Thymocytes from
WT*/WT* or T490/T490A mice were fractionated
by centrifugal elutriation. Progression from 2C
(G0-G1) to 4C (G2-M) DNA content is indicated
below. Fractions were assayed for RAG-2 by
immunoblotting. C, invariant, cross reactive
species, used as an internal control.
(D) Accumulation of RSS breaks is uncoupled from
cell cycle in RAG-2(T490A) mice. Thymocytes
from neo-excised wild-type (WT*/WT*) or mutant
(T490A/T490A) mice were sorted into fractions of
2C or >2C DNA content. Double-strand DNA
breaks at Jb2.5, 30Db2, and 50Db2 RSSs (indicated
at left) were assayed by LM-PCR amplification of
genomic DNA. A portion of the Rag1 gene was
amplified in parallel to monitor the amounts of
genomic DNA in each reaction.
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RAG-2 may sequester DNA ends temporally from alternative
and potentially harmful modes of repair.
RESULTS
A RAG-2 T490A Mutation Uncouples Accumulation
of RAG-2 and RSS Breaks from the Cell Cycle
A mutation specifying RAG-2(T490A) was introduced into ES
cells by homologous recombination, via a targeting construct
bearing a neomycin resistance marker (neo) flanked by loxP
sites. As a control, the wild-type Rag2 locus was tagged with
a floxed neo marker. The Rag2(T490A) allele was marked with
a PstI restriction site and could thus be distinguished from
wild-type (Figure 1A). ES cells were used to obtain chimeric
mice capable of transmitting the modified alleles in the germline
and floxed sequences were deleted by mating with cre trans-
genic females. In this way we obtained mice bearing targeted,164 Immunity 34, 163–174, February 25, 2011 ª2011 Elsevier Inc.excised wild-type (WT*) and Rag2(T490A) alleles (Figure 1B). In
all experiments reported here, results were similar for wild-type
(WT) mice and mice bearing the WT* allele.
Accumulation of RAG-2 was uncoupled from the cell cycle in
RAG-2(T490A) mutant mice. Thymocytes were fractionated
according to cell cycle phase and assessed for DNA content
and RAG-2 protein. In WT*/WT* mice, as expected, RAG-2
accumulated preferentially in thymocytes with 2C DNA content
(Figure 1C). In contrast, accumulation of RAG-2(T490A) per-
sisted throughout the cell cycle in thymocytes from homozygous
mutant (T490A/T490A) mice (Figure 1C).
Recombination signal end intermediates normally accumulate
preferentially in the G0 and G1 cell cycle phases. We examined
the cell cycle distribution of signal ends in pooled thymocytes
from eight WT*/WT* and eight T490A/T490A mice. Recombina-
tion signal ends were assayed at three sites within the T cell
receptor (TCR) b locus: the 50 flank of Jb2.5, the 50 flank of Db2,
and the 30 flank of Db2. In WT*/WT* mice signal ends were
Figure 2. Analysis of Lymphoid Lineages in RAG-2
(T490A) Mice
(A) Flow cytometric analysis of thymocytes from homozy-
gous RAG-2 wild-type (WT/WT), neo-excised RAG-2 wild-
type (WT*/WT*), and RAG-2(T490A) (T490A/T490A) mice.
Top, thymocytes assayed for CD4 and CD8; bottom,
thymocytes, gated on the CD4CD8 population, as-
sayed for CD44 and CD25.
(B) Flow cytometric analysis of bone marrow cells, as-
sayed for B220 and CD43, from homozygous RAG-2
wild-type (WT/WT), neo-excised RAG-2 wild-type
(WT*/WT*), and RAG-2 T490A (T490A/T490A) mice.
Percentages of cells within each quadrant are indicated.
(C) Reduction of thymic cellularity in homozygous RAG-2
(T490A) mice, relative to wild-type. Circles (WT/WT) and
squares (T490A/T490A) represent cellularity of thymuses
from individual mice; horizontal bars indicate mean cellu-
larity. Significance was estimated by the two-tailed t test.
(D) Increased apoptosis among CD4CD8 thymocytes
from RAG-2(T490A) mice. Symbols represent individual
mice; horizontal bars indicate mean percentages. Geno-
types are indicated in inset at right. Significant differences
are indicated with confidence limits as determined by the
two-tailed t test.
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expected. In T490A/T490A mice, however, signal ends were
readily detected in the G0-G1 and S-G2-M thymocyte popula-
tions (Figure 1D). Signal ends at the 30 flank of Db2were detected
inS-G2-Mphase thymocytes frommutantmice at at least half the
level observed in G0-G1 phase cells (Figure S1 available online).
Signal ends at Vb14, which undergoes inversional rearrange-
ment, must be repaired tomaintain chromosomal integrity; these
endswere also observed to accumulate in S-G2-Mphase thymo-
cytes frommutantmice (Figure S1).We conclude that accumula-
tion of RAG-2 and accumulation of recombination intermediates
are uncoupled from the cell cycle in RAG-2(T490A) mutant mice.Immunity 34, 163Increased Frequency of Aberrant V(D)J
Recombination in Mice Expressing RAG-
2(T490A)
Lymphocyte development was grossly normal
in T490A/T490A mice (Figures 2A and 2B). The
mutant mice did, however, show decreased
thymic cellularity (Figure 2C) and an increase
in the frequency of apoptotic cells in the
CD4CD8 compartment, where TCRb, g, and
d gene rearrangement occurs (Figure 2D; Fig-
ure S2). Notably, apoptosis was similarly
increased in heterozygous and homozygous
mice, consistent with dominance of the T490A
allele. These observations suggested that DNA
ends produced by unscheduled cleavage might
undergo alternative fates that invoke cell loss.
We therefore sought evidence for abnormal
recombination in mice expressing RAG-2
(T490A).
Signal joints (SJs) generated by V(D)J recom-
bination are more sensitive indicators of aber-
rant recombination than coding joints because
their junctional sequences are relatively simple.We examined SJs produced by inversional recombination
between the TCR gene segments Vb14 and Db1 or Vd5 and
Dd2, because these products are retained in the genome. SJs
were amplified from thymocyte DNA and cloned; precise SJs
were identified by ApaL1 digestion. The nucleotide sequences
of imprecise, ApaL1-resistant fragments were determined.
Imprecise SJs infrequently occur at TCR loci in wild-type mice,
generally as a result of N region addition (Akamatsu et al.,
2003; Candeias et al., 1996; Touvrey et al., 2006). We classified
an imprecise SJ as aberrant if it carried a deletion, an insertion of
genomic sequence, or both. For Vd5-Dd2 SJs, which, unlike
Vb14-Db1 SJs, often exhibit small deletions in the wild-type–174, February 25, 2011 ª2011 Elsevier Inc. 165
Figure 3. Increased Recovery of Aberrant Vb14-Db1 Signal Joints from Mice Expressing RAG-2(T490A) or Deficient in Skp2
Vb14 and Db1 RSSs and flanking coding sequences shown at top. Heptamer and nonomer elements are indicated in boldface; coding sequences are underlined
and capitalized. In each sequence below, the RSSs are in lowercase and insertions in uppercase. Sets of sequences from RAG-2 wild-type, RAG-2(T490A),
Skp2+/, and Skp2/ animals are indicated. Nucleotide additions of more than three contiguous bases identical to either coding flank are capitalized in blue.
The sizes of deletions from each signal end, in bp, are given in parentheses. Potential microhomologies are indicated in red type. The number of junctions
obtained for a given sequence is indicated at right.
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of%7 bp from either end from those ofR15 bp (Table S1).
Of 102 Vb14-Db1 SJs from wild-type (WT/ WT and WT*/ WT*)
mice, 8 were imprecise as a consequence of N region addition
(Figure 3; Table S1). Of 60 Vb14-Db1 SJs from T490A/T490A
mice, 12 were imprecise. In contrast to the wild-type junctions,
half of the imprecise SJs from mutant mice were aberrant (Fig-
ure 3; Table S1). Of 143 Vd5-Dd2 SJs from wild-type mice, 37
were imprecise; of these, 18 were classified as aberrant because
of small (%7 bp) deletions from one or both signal ends
(Figure 4A; Table S1). Of 75 Vd5-Dd2 SJs from RAG-2(T490A)
mutant mice, 21 were imprecise and 12 were classified as aber-
rant. The aberrant SJs from mutant mice differed from those of
wild-type, however, in that 7 of 12 exhibited large deletions
(R15 bp), insertions corresponding to genomic sequence, or
both. The insertions were apparently derived from adjacent
coding flanks or nonadjacent genomic sequence (Figure 4A;166 Immunity 34, 163–174, February 25, 2011 ª2011 Elsevier Inc.Table S1). One 95 bp insertion was derived from the Jd1 RSS
and its 50 flank; a 54 bp insertion contained a fusion between
Dd2 and the Vd5 RSS, as well as partial tandem repeats of the
Dd2 12 RSS (Figure 4A). Microhomology of greater than 1 bp
was observed only twice in the 18 aberrant SJs obtained from
mutant mice. These observations suggest abnormal repair of
recombinase-induced breaks by a mechanism involving clas-
sical, rather than alternative, NHEJ. Similar aberrations (Talukder
et al., 2004) have been observed at SJs frommice carrying a trun-
cation that removes the entire noncore region of RAG-2, which
spans residues 387 through 527.
We also examined coding joints produced by inversional
recombination between Vb14 and Db1Jb1 in mice expressing
RAG-2(T490A). With respect to junctional modification and dele-
tion from the J or D segment, these coding joints were similar to
those from wild-type mice (Figure S3 and Table S2). A small but
significant increase in the average length of deletion from the
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(Table S2), as has been documented in mice in which the
RAG-2 noncore region is deleted (Talukder et al., 2004).
Mistargeted DNA cleavage by the mutant recombinase could
formally account for some of the aberrant SJs from RAG-2
(T490A) mice. To examine this, we tested RAG-2(T490A) in an
assay for DNA cleavage in vitro (Bergeron et al., 2006). In the
presence of core RAG-1, wild-type RAG-2 and RAG-2(T490A)
supported similar amounts of nicking and transesterification on
12-RSS and 23-RSS substrates; importantly, we observed no
difference between wild-type and mutant RAG-2 with respect
to off-target nicking or transesterification (Figure S4A). We also
compared wild-type RAG-2 and RAG-2(T490A) in extrachromo-
somal assays for recombination and failed to observe a signifi-
cant difference with respect to the frequency or fidelity of SJ
formation (Figure S4B). Taken together, these results suggest
strongly that the aberrant features of SJs from RAG-2(T490A)
mice are introduced after the appropriately targeted cleavage
of endogenous gene segments.
Aberrant V(D)J Recombination in Mice Lacking
the Skp-2-SCF Ubiquitin Ligase
It remained possible that the effect of the T490A mutation on
the repair of RAG-induced DNA breaks was independent of
its effect on the periodic degradation of RAG-2. To address
this, we sought a setting in which accumulation of RAG-2 is
relieved from cell cycle control without alteration of the RAG-
2 protein itself. The Skp2-SCF E3 ubiquityl ligase is responsible
for programmed destruction of RAG-2; thus, in Skp2-deficient
thymocytes, RAG-2 persists throughout the cell cycle (Jiang
et al., 2005). We reasoned that if the aberrant SJs recovered
from RAG-2(T490A)-expressing mice were the result of mis-
timed RAG activity, then an increase in the yield of aberrant
recombination products would also be observed in Skp2-
deficient mice.
We compared Vb14-Db1 SJs from Skp2+/ and Skp2/
thymocytes. No aberrant junctions were found among 68
Vb14-Db1 SJ sequences recovered from Skp2+/mice (Figure 3;
Table S3). In contrast, 14 of 33 Vb14-Db1.1 SJ sequences recov-
ered from Skp2/ thymocytes were aberrant according to
criteria defined above. We also examined Vd5-Dd2 SJs from
Skp2+/ and Skp2/ thymocytes. Of 77 Vd5-Dd2 signal
sequences recovered fromSkp2+/ thymocytes, 4 were aberrant
because of small (%7 bp) deletions from one or both signal ends
(Figure 4B; Table S3). In contrast, among 125 Vd5-Dd2 signal
sequences recovered from Skp2/ thymocytes, 28 were aber-
rant; of these, 16 exhibited long deletions ranging from 15 bp
to 295 bp at either end (Figure 4B; Table S3). In two aberrant
sequences, the Dd2 coding sequence was represented intact
and bounded at one end by potential P elements and N additions
(Figure 4B). No microhomology of greater than 1 bp was
observed among the aberrant SJs from Skp2/ mice, consis-
tent with the infrequency of microhomology at SJs from RAG-2
(T490A)-expressing animals. The difference in recovery of aber-
rant recombination products from Skp2+/ and Skp2/ animals
at TCRb (p < 0.0001) and TCRd (p = 0.0012) is highly significant
(Table S3) and consistent with the interpretation that DNA breaks
produced by RAG outside of G0-G1 are subject to noncanonical
repair.Unscheduled RAG Activity Is Associated with Lymphoid
Tumors Bearing Complex Chromosomal Translocations
Involving Antigen Receptor Loci
The frequent aberrant rearrangement and increased apoptosis
in mice expressing RAG-2(T490A) suggested that removal of
p53 might unmask oncogenic effects of the RAG-2(T490A)
mutation, by analogy to the effects of combined NHEJ
and p53 deficiency. We introduced the Rag2(T490A) allele or
the WT* allele onto a p53-deficient background. About half of
the single-mutant (Rag2wt*/wt*, Trp53/ and Rag2wt/wt,
Trp53/) mice developed T cell lymphomas by 20 weeks (Fig-
ure S5A), consistent with previous studies (Jacks et al., 1994).
Double-mutant (Rag2T490A/wt, Trp53/ and Rag2T490A/T490A,
Trp53/) mice exhibited a tumor latency similar to that of the
p53-null animals but with a distinctive tumor phenotype. The
single-mutant, p53-null animals did not develop B lymphoid
tumors (Figure S5B), whereas one fourth of the malignancies
arising in RAG-2(T490A), p53-null mice were B lymphomas
(Table 1; Figure S5B). Moreover, whereas T lymphomas
from single-mutant, p53-deficient mice were CD4+CD8+, as
expected (Jacks et al., 1994), most T lymphomas from
double-mutant mice were of the less mature CD4CD8
or CD4CD8 intermediate single-positive (CD4CD8 ISP)
phenotypes (Table 1).
Spectral karyotypic analysis revealed robust differences
between the lymphomas arising in the double-mutant mice and
those associated with p53 deficiency alone. Lymphomas from
p53-deficient mice rarely exhibit clonal chromosomal transloca-
tions (Haines et al., 2006). The T lymphomas from Rag2wt/wt,
Trp53/ and Rag2wt*/wt*, Trp53/ mice were consistent with
these observations (Figure 5A; Table 1). In contrast, seven of
eight lymphoid tumors analyzed from Rag2T490A/wt, Trp53/
and Rag2T490A/T490A, Trp53/mice carried clonal chromosomal
translocations (Figure 5A; Table 1). In all seven of these tumors,
at least one translocation involved a chromosome carrying an
antigen receptor locus. In most cases multiple clonal transloca-
tions were observed. Two T lymphomas carried complex clonal
translocations (Table 1) and in one tumormore than one complex
translocation was observed (Figure S5C).
Mapping of Translocation Breakpoints to Antigen
Receptor Loci in Lymphomas from RAG-2(T490A)
Mutant Mice
Rearrangements involving chromosome 14, which carries the
TCRa and TCRd locus, were found in all T lymphomaswith clonal
translocations (Table 1). We used chromosome painting and
fluorescence in situ hybridization (FISH) to localize the t(12;14)
translocation breakpoint relative to the TCRa and TCRd locus
in tumor 2297, a T cell lymphoma from a p53-deficient, RAG-2
(T490A) mutant mouse. As a reference, we performed a similar
analysis with tumor 2319, a polyploid T cell lymphoma derived
from a p53-deficient mouse expressing wild-type RAG-2. In
both tumors a probe specific for the TCRa and TCRd locus
hybridized to a site within intact chromosome 14, as expected
(Figure 5B). In the t(12;14) translocation of tumor 2297, the
TCRa and TCRd locus resided near the translocation boundary
(Figure 6B, bottom). Further analysis showed that the t(12;14)
translocation in tumor 2297 splits the TCRa and TCRd locus (Fig-
ure 5C), because the translocation boundary was stained byImmunity 34, 163–174, February 25, 2011 ª2011 Elsevier Inc. 167
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TCRa and TCRd locus (Figure 5C).
Rearrangements involving chromosome 12, which carries the
IgH locus, were found in both B lymphomas that were analyzed
by spectral karyotyping (Table 1). The B220+IgM+IgD+CD43+
tumor 2135 (Figure 6A), which carries a t(12;16) translocation
(Table 1), was analyzed by FISH. Probes specific for telomeric
(50, red) and centromeric (30, green) regions of the IgH locus
hybridized near each another in intact chromosome 12 (Fig-
ure 6B). In contrast, the t(12;16) translocation was stained by
the 30-specific probe, but not by the 50-specific probe (Figure 6B),
indicating that the translocation boundary splits the IgH locus.
Moreover, the region stained by the 30-specific probe was
broader at the t(12;16) translocation than at the intact locus, indi-
cating amplification near the translocation boundary (Figure 6B,
inset). Taken together, these observations suggest that persis-
tence of RAG activity throughout the cell cycle predisposes to
aberrant V(D)J recombination and, in the context of p53 defi-
ciency, to genomic instability and malignant transformation.
DISCUSSION
Several lines of evidence implicate V(D)J recombination in the
genesis of lymphoid tumors. First, chromosomal translocations
involving antigen receptor loci and protooncogenes are often
observed in human lymphomas (Marculescu et al., 2006). A
subset of such translocations may arise from aberrant V(D)J
recombination events, involvingmistargeting of the recombinase
to cryptic, nonconsensus RSSs or joining of RAG-induced
breaks to DNA ends created by other means, such as radiation
(Marculescu et al., 2006). Second, impairment of NHEJ, in
combination with p53 deficiency, promotes development of B
cell lymphomas in mice (Difilippantonio et al., 2000; Gao et al.,
2000; Zhu et al., 2002). These tumors typically exhibit clonal
translocations involving the IgH locus and the Myc protoonco-
gene and apparently result from misrepair of RAG-induced
DNA breaks (Difilippantonio et al., 2000; Gao et al., 2000; Zhu
et al., 2002). In the absence of NHEJ, the V(D)J recombinase
can confer genomic instability even in the periphery (Wang
et al., 2009). Third, double-strand break surveillance proteins,
including ATM and H2AXg, accumulate at sites of RSS cleavage
and may suppress oncogenic translocations associated with V
(D)J recombination (Bassing et al., 2003; Bredemeyer et al.,
2006; Callen et al., 2007; Celeste et al., 2002; Chen et al.,
2000; Perkins et al., 2002).
We have now shown that mutation of the cyclinA-CDK2
phosphorylation site within RAG-2, in combination with p53
deficiency, promotes the generation of B and T lymphomas.
These tumors bear clonal chromosomal translocations whoseFigure 4. Increased Recovery of Aberrant Vd5-Dd2 Signal Joints from
(A) Comparison of Vd5-Dd2 SJs from wild-type and RAG-2(T490A) knockin mic
Figure 3. Deletions, potential microhomologies, and numbers of isolates are des
or to other genomic sequence are indicated in capitals and blue type. The prese
underline. A portion of the Jd1 upstream flank within the same insertion is underlin
is underlined in black and partial tandem repeats of the Dd2 12 RSS are undersc
(B) Comparison of Vd5-Dd2 SJs from Skp2+/ and Skp2/ mice. Top, Vd5 and D
potential microhomologies, and numbers of isolates are designated as in Figure 3
the reference shown at top. Insertions corresponding to flanking coding sequencbreakpoints lie within antigen receptor loci. Mice expressing
RAG-2(T490A) on a p53-deficient background developed
lymphoid tumors that were phenotypically more mature than
those from p53-null, NHEJ-deficient animals. This may be ex-
plained, at least in part, by the fact that in NHEJ-deficient mice
lymphoid development is arrested at the pro-B and pro-T stages.
The long latency of tumors from RAG-2(T490A), p53-deficient
mice, relative to those associated with NHEJ deficiency (Difilip-
pantonio et al., 2000; Gao et al., 2000), may reflect the intactness
of NHEJ in the RAG-2(T490A), p53-deficient animals.
The broad spectrum of chromosomal translocations in tumors
from RAG-2(T490A), p53-deficient mice is reminiscent of that
seen in human T cell acute lymphoblastic leukemia (T-ALL).
Translocations of the TCRa and TCRd locus occur in about
20% of T-ALL tumors and involve at least seven different recom-
bination partners (Marculescu et al., 2006). The spectrum of
translocations in tumors from RAG-2(T490A), p53-deficient
mice was also broader than that seen in NHEJ-deficient,
p53-deficient animals, which typically harbor one to a few domi-
nant translocations (Difilippantonio et al., 2000; Gao et al., 2000;
Zhu et al., 2002). The diversity of T lymphomas arising in RAG-2
(T490A), p53-deficient mice suggest that the events initiating
translocation in these animals may be more promiscuous and
occur over a longer developmental interval than those in
NHEJ-deficient, p53-deficient mice.
The high frequency of aberrant signal joining in RAG-2(T490A)
mice is most easily explained by defective repair of RAG-
induced DNA breaks, which may in turn underlie the IgH and
TCR translocations in lymphomas from these mice. These aber-
rant events are likely to result from the persistence of RAG
activity throughout the cell cycle, because similarly aberrant
SJs also accumulate in mice lacking Skp2, which mediates
destruction of RAG-2 at the G1-S transition (Jiang et al., 2005).
Several additional considerations argue that anomalous recom-
bination in RAG-2(T490A)-expressing mice does not result from
a change in the intrinsic activity of RAG-2. First, the T490Amuta-
tion had no discernable effect on the specificity of DNA cleavage
in vitro. Second, failure to degrade RAG-2(T490A) at the G1-S
transition is unlikely to hinder repair because wild-type RAG-2
and RAG-2(T490A) support SJ formation with similar efficiency.
Third, although the T490Amutation could have impaired an inter-
action of RAG with NHEJ components, the ability of Skp2 defi-
ciency to phenocopy RAG-2(T490A) with respect to aberrant
joining argues that loss of programmed RAG-2 degradation is
responsible for this phenotype.
There are at least twoways to explain the appearance of signal
ends in S-G2-M phase thymocytes from RAG-2(T490A) mice: (1)
de novo DNA cleavage outside of G0-G1 and (2) carryover of
ends from G0-G1 because of a failure to degrade RAG-2. TheMice Expressing RAG-2(T490A) or Deficient in Skp2
e. Top, Vd5 and Dd2 RSSs and flanking coding sequences, annotated as in
ignated as in Figure 3. Insertions corresponding to flanking coding sequence
nce of a partial Jd1 RSS within one junctional insertion is designated by a red
ed in black. In a separate junctional insertion, a complete Dd2 coding sequence
ored by red arrows.
d2 RSSs and flanking coding sequences, annotated as in Figure 3. Deletions,
. Italics denote sequences surrounding deletions whose endpoints lie beyond
e are indicated in capitals and blue type; potential P elements are underlined.
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Table 1. Clonal Chromosomal Translocations in Lymphoid Tumors from p53-Deficient, RAG-2(T490A) Mutant Mice
Mouse Genotype Lineage Phenotype
Metaphases
Examined
Chromosome
Number Aberrations Frequency
2207 WT/WT, Trp53/ T cell CD4+CD8+ 10 43–45 (45) Rb(5;5) 10/10
Rb(6;6) 10/10
Rb(16;16) 10/10
Rb(17;15) 10/10
Rb(1;1) 4/10
2319 WT/WT, Trp53/ T cell CD4+CD8+ 10 67–69 (69) dic(5;5) 10/10
3265 WT/WT, Trp53/ T cell CD4+CD8+ 14 47 N.D. 14/14
3486 WT/WT, Trp53/ T cell CD4+CD8+ 14 35–42 (41) N.D. 14/14
2266 WT*/WT*, Trp53/ T cell CD4+CD8+ 6 42 N.D. 6/6
2409 T490A/WT, Trp53/ T cell CD4+CD8+ 9 29–38 (37) t(17;14) 9/10
t(4;16) (reciprocal) 9/10
t(15;1) 1/10
Rb(5;5) 10/10
Rb(15;15) 10/10
Rb(X;X) 9/10
2371 T490A/WT, Trp53/ T cell CD4+CD8+ 7 37–47 (47) t(7;14;15;5) 7/7
t(7;5;15) 7/7
t(16;14) 6/7
t(7;16;15) 6/7
2361 T490A/WT, Trp53/ T cell CD4CD8 ISP 7 27–43 (43) Rb(5;5) 3/7
t(3;16) 1/7
2297 T490A/T490A, Trp53/ T cell CD4CD8 ISP 16a 37–46 (44) t(2;5) (reciprocal) 6/6b
t(12;14) 12/16c
2415 T490A/T490A, Trp53/ T cell CD4CD8 ISP 10 35–44 (42) t(4;14) 10/10
t(19;16) 9/10
Rb(4;4) 9/10
Rb(17;15) 9/10
2352 T490A/T490A, Trp53/ T cell CD4CD8 14 58–65 (60) t(17;14;1) 13/14
t(14;15) 1/14
Rb(4;4) 14/14
2118 T490A/WT, Trp53/ B cell B220+IgM+IgD+ 10 28–40 (40) t(10;12) 10/10
t(10;19) 1/10
2135 T490A/WT, Trp53/ B cell B220+IgM+IgD+ 12 47 t(12;16) 12/12
For each tumor the genotype of origin, lineage, and cell surface phenotype are given. The number of metaphase nuclei examined is followed by the
chromosome number. If ploidy varied among nuclei from the same tumor, a range is given, followed by the modal chromosome number (in paren-
theses). Each chromosomal aberration detected is defined, together with the frequency with which it was observed among metaphase nuclei. t, trans-
location; (reciprocal), reciprocal translocation. Rb, Robertsonian; dic, dicentric; N.D., none detected. A translocation is defined as clonal if present in
R75% of metaphase nuclei examined.
a 6 metaphases analyzed by SKY; 10 metaphases analyzed by painting chromosomes 12 and 14.
bOnly metaphases analyzed by SKY included.
c Combined results of SKY and chromosome painting.
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inversional signal ends, which must be joined to avoid cell cycle
arrest, apoptosis, or chromosome loss, may provide indirect
evidence for de novo cleavage in S-G2-M. Nonetheless, if pro-
grammed degradation of RAG-2 plays a role in disassembly of
signal end complexes, the T490A mutation may promote carry-
over of signal ends into S-G2-M, particularly because signal
end complexes are more stable than complexes containing
coding ends.170 Immunity 34, 163–174, February 25, 2011 ª2011 Elsevier Inc.The RAG-2 degradation signal lies within the 140 residue non-
core region, which is dispensable for DNA cleavage in vitro.
Wholesale deletion of the noncore region is associated with
reduced efficiency of recombination (Cuomo and Oettinger,
1994; Kirch et al., 1998; McMahan et al., 1997; Sadofsky et al.,
1993, 1994; Steen et al., 1999), impaired VH-to-DJH joining (Aka-
matsu et al., 2003; Kirch et al., 1998; Liang et al., 2002),
increased production of hybrid joints (Sekiguchi et al., 2001),
aberrant signal joining (Talukder et al., 2004), disordered
Figure 5. A t(12;14) Translocation Splits the TCRa and TCRd Locus in a T Cell Lymphoma from a p53-Deficient, RAG-2(T490A) Mouse
(A) Spectral karyotypic (SKY) analysis ofmetaphase chromosomes from tumor 2319 (Rag2wt/wt, Trp53/; top) or tumor 2297 (Rag2T490A/T490A, Trp53/; bottom).
SKY images are shown at left and DAPI-stained images at right. Arrows, aberrant chromosomes; n, ploidy. Enlarged images of each aberrant chromosome are
given below; chromosomal origins are indicated; t, translocation; dic, dicentric. The karyotypic analyses of all tumors examined in this study are summarized in
Table 1.
(B) Translocation breakpoint of t(12;14) translocation in tumor 2297 lies at or near the TCRa and TCRd locus. Fluorescence in situ hybridization (FISH) to meta-
phase chromosome spreads fromRag2wt/wt, Trp53/ tumor 2319 (top) orRag2T490A/T490A, Trp53/ tumor 2297 (bottom) with a TCRa- and TCRd-specific probe
(green) and a chromosome 14-specific probe (red). Normal chromosomes 14 (14), the deleted portion of chromosome 14 (del[14]), and the position of the TCRa
and TCRd locus are indicated.
(C) The t(12;14) translocation breakpoint in tumor 2297 lies within the TCRa and TCRd locus. FISH was performed against metaphase chromosome spreads from
Rag2wt/wt, Trp53/ tumor 2319 (top) or Rag2T490A/T490A, Trp53/ tumor 2297 (bottom) with probes specific for the 50 (green) or 30 (red) regions of the TCRa and
TCRd locus. The inset in the top panel represents an enlarged image of intact chromosome 14, exhibiting superimposed signals from 50 and 30 probes. The inset in
the bottom panel represents an enlarged image of the t(12;14) translocation, which hybridized only to the 30 probe. The deduced arrangements of hybridized
probes in intact chromosome 14 and the t(12;14) translocation are diagrammed below.
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Genomic Integrity Conferred by RAG-2 Destructionrearrangement (Curry and Schlissel, 2008), and imprecise selec-
tion of cleavage sites (Curry and Schlissel, 2008). The mecha-
nisms underlying these effects have remained unclear and are
likely to be complex, because the noncore region subsumes
several functions in addition to degradation, including interaction
with modified chromatin (Liu et al., 2007; Matthews et al., 2007)
and nuclear import (Ross et al., 2003). We infer that the aberrant
junctions associated with deletion of the noncore region (Ta-
lukder et al., 2004), which resemble those from RAG-2(T490A)
and Skp2/ mice, result from a failure to destroy RAG-2 at the
G1-S transition.
Some translocation junctions from human lymphomas involve
the joining of RSS ends to non-RSS-mediated breaks (Marcu-
lescu et al., 2006). These junctions and similar ones modeled
in cell culture (Lieber et al., 2006) often contain templated inser-
tions, or T nucleotides, that appear to have been copied from
sites at or near the participating DNA ends. Some insertions at
aberrant SJs from RAG-2(T490A) or Skp2/ mice also contain
apparent T nucleotides. The presence of tandem duplications
at several of these junctions suggests involvement of a replicative
mechanism such as break-induced replication (BIR).Two junctions from Skp2/ mice include a Dd2 coding
sequence, flanked on one end by an apparent P element, an
N region, and the Vd5 RSS. Although these insertions could
have been formed by templated synthesis, the presence of
a P element is consistent with RAG-mediated cleavage and
suggests two alternative ways in which the Dd insertion could
have been formed. One mechanism, consistent with the 12-23
rule, would involve Vd5-to-Dd1 joining, followed by a secondary
rearrangement between the retained Vd5-Dd1 SJ and Dd2.
Another mechanism would invoke recombination between the
30 RSS of Vd5 and the 30 RSS of Dd2, in violation of the 12-23
rule. Secondary rearrangement of retained SJs and violations
of 12-23 joining have both been observed at the TCRd locus
(Carroll et al., 1993).
Aberrant SJs were more frequently recovered from Skp2-
deficientmice than fromRAG-2(T490A)mice. This need not imply
a distinction in cleavage or repair; antigen receptor loci them-
selves differ with respect to the frequency of aberrant joining.
Whereas Skp2-deficient mice exhibit specific cell cycle defects,
including G1-to-S delay (Nakayama et al., 2000), impairment of
the G2-to-M transition, and endoduplication (Nakayama et al.,Immunity 34, 163–174, February 25, 2011 ª2011 Elsevier Inc. 171
Figure 6. A t(12;16) Translocation Splits and
Amplifies a Portion of the IgH Locus in a B Cell
Lymphoma from a p53-Deficient, RAG-2(T490A)
Mouse
(A) Flowcytometric analysis of tumor 2135 (Rag2T490A/T490A,
Trp53/) indicates a tumor of B lymphoid origin.
Dispersed tumor cells were stained for the surface
markers B220 and Thy1.2 (top), CD43 (middle), and IgM
(bottom).
(B) Analysis of a metaphase spread from the same tumor
by FISH with BAC probes specific for the 50 flank of the
IgH locus (red) and the 30 flank of the IgH locus (green).
Inset represents an enlarged image of t(12;16), which had
been detected bySKY analysis (see Table 1). The deduced
arrangements of probes in intact chromosome12 and the
t(12;16) translocation are indicated below.
Immunity
Genomic Integrity Conferred by RAG-2 Destruction2000, 2004), no effects on DNA repair have been reported. Skp2
deficiency is not known to increase the frequency of lymphoid
tumors. Although it would be reasonable to expect Skp2 defi-
ciency to promote lymphomagenesis on a p53-null background,
any prolymphomagenic effect may be mitigated by the debili-
tating effect of Skp2 deficiency on cell cycle progression.
Periodic destruction of RAG-2may temporally sequester V(D)J
recombination intermediates from HR by restricting DNA
cleavage to times at which HR is minimally active (Takata
et al., 1998). The T nucleotides associated with RSS-mediated
chromosomal translocations have been proposed to involve
the combined actions of NHEJ and abortive HR (Marculescu
et al., 2006). If this is true, then a breakdown in the segregation
of RAG-induced DNA breaks from HR might increase the
frequency of such events. Persistent RAG activity could produce
RSS ends at times when HR is active and when potential
templates for repair are present as sister chromatids. Under
these conditions, RAG-induced double-strand breaks would
remain available to NHEJ but could also be acted upon by
factors associated with HR. Repair of RAG-induced DNA breaks
through a combination of NHEJ and mechanisms associated
with HR (Marculescu et al., 2006), such as BIR (Zhang et al.,
2009), may explain the SJ aberrations seen in RAG-2(T490A)
and Skp2-deficient mice. The rarity of such events in wild-type
mice is consistent with a model in which restriction of V(D)J
recombinase activity to the G1 cell cycle phase isolates RAG-
induced DNA breaks from unproductive pathways of repair.
EXPERIMENTAL PROCEDURES
Assay for V(D)J Recombination Intermediates
Genomic DNA was prepared from thymocytes of 7- to 10-day-old mice,
sorted into fractions of 2C or >2C DNA content as described (Li et al., 1996).
Double-strand breaks at recombination signal sequences were detected by
ligation-mediated PCR (Schlissel et al., 1993) and products were detected172 Immunity 34, 163–174, February 25, 2011 ª2011 Elsevier Inc.by hybridization to locus-specific oligonucleotide probes.
For details see Supplemental Experimental Procedures.
Spectral Karyotyping and Fluorescence In Situ
Hybridization
Tumor cells were maintained in culture for 48–72 hr and
metaphase arrest was induced by colcemid. After fixation,
cells were dropped onto slides to obtain chromosome
spreads. Spectral karyotyping (SKY) and single-chromo-some painting were performed with commercial fluorescent probes (SKY-
Paint, Applied Spectral Imaging). Mouse BAC clones corresponding to the 50
and 30 ends of the TCRa and TCRd or IgH locus were used as probes for
fluorescence in situ hybridization (FISH). For details see Supplemental
Experimental Procedures.
Analysis of Recombinant Signal Junctions
Vb14-Db1 signal joints (SJs) were amplified from thymocyte genomic DNAwith
the primers Vb14SIGNAL and Db1.1SIGNAL (Talukder et al., 2004); Vd5-Dd2
SJs were amplified from RAG-2(T490A) mice with primers SR1 and SR2
(Talukder et al., 2004) and from Skp2-deficient mice with nested primers
TCRVd5A and TCRDd2B (outside) and TCRVd5C and TCRDd2D (inside). The
sequences of these primers are given in Supplemental Experimental Proce-
dures. Amplicons were introduced into plasmid pCR2.1-TOPO by TA cloning
(Invitrogen) and propagated in E. coli; individual colonies were selected for
analysis. Precise SJs were identified by digestion with ApaLI. Imprecise,
ApaLI-resistant junctions were analyzed further by nucleotide sequencing.
In Vitro DNA Cleavage Assays
RAG fusion proteins were purified by amylose affinity chromatography as
described (Bergeron et al., 2006). DNA cleavage reactions were performed
in Mg2+ with the 12-RSS substrate DAR39/DAR40 or the 23-RSS substrate
DAR61/DAR62 as described (Bergeron et al., 2006) except that core RAG-1
and full-length RAG-2 or RAG-2(T490A) were added at 200 ng each and
HMG1 was added to a concentration of 4 mg/ml. Reactions were carried out
at 37C for the indicated times. Reaction products were fractionated by
electrophoresis through a 15% denaturing polyacrylamide gel and detected
with a phosphorimager.
Extrachromosomal Recombination Assays
Assays were performed as described (Hesse et al., 1987) with slight modifica-
tion. In brief, plasmids (10 mg) encoding MBP-RAG-1-myc-His and RAG-2 or
RAG-2(T490A) were cotransfected with 4 mg pJH200 (Lieber et al., 1988) into
NIH 3T3 cells with Lipofectamine 2000 (Invitrogen). Plasmid DNA was isolated
40–48 hr after transfection with a miniprep kit (QIAGEN). E. coli DH5a was
transformedwith 1 ml (about 40 ng) plasmid DNA and 1.7%of each transforma-
tion mix was plated on LB agar containing 50 mg/ml ampicillin; the remainder
was plated on LB agar containing 50 mg/ml ampicillin and 12.5 mg/ml chloram-
phenicol. Plates were scored after 14–16 hr at 37C.
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Genomic Integrity Conferred by RAG-2 DestructionGene Targeting, Generation of Mutant Mice, Antibodies and Flow
Cytometry, Elutriation of Neonatal Thymocytes, Statistical Analysis,
and Oligonucleotides
See Supplemental Experimental Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
five figures, and three tables and can be found with this article online at
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